¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31
±³À°ÀÏÀÚ : 2024-05-31
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ¿¬±¸°ü

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 13:30~14:00 Clinical significance of BRAFV600E-positive cells as measurable residual disease (MRD) in Langerhans cell histiocytosi Ko Kudo(Hirosaki University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:00~14:30 How we treat LCH(Langerhans cell histiocytosis) in Taiwan Grace Yu Mei Liao(Medical University, Taiwan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:30~15:00 Unraveling the Genetic Tapestry of Langerhans Cell Histiocytosis in Korean Patients °í°æ³²(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:15~15:45 Stratified treatment of pediatric HLH(Hemophagocytic lymphohistiocytosis) Rui Zhang(Capital  Medical University, China)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:45~16:15 Primary and secondary hemophagocytic lymphohistiocytosis in Japan Shouichi Ohga(Kyushu University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 16:15~16:45 HLH(Hemophagocytic lymphohistiocytosis) in Korea ÃÖÁ¤À±(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:00~17:30 CAR-T related CSS & cytopenia Yoshiyuki Takahashi(Nagoya University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:30~18:00 CAR-T related HLH(Hemophagocytic lymphohistiocytosis) À¯Àç¿ø(°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29
´ÙÀ½±Û ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
1397 ¼­¿ï ´ëÇѳ²¼º°úÇÐȸ 2018 International Joint Meeting of Men¡¯s Health and Aging : 2018-11-04 0 704 2018-10-11
1396 ±¤ÁÖ 2018 ´ëÇѳúÀüÁõÇÐȸ Annual Update of Epilepsy (³úÀüÁõÀÇ ÃÖ½ÅÁö°ß) : 2018-11-04 0 377 2018-10-11
1395 ¼­¿ï ¼öºÎ¿Ü°úÃÖ½ÅÇغÎÇÐ, ¼öºÎ¿Ü°úÃÖ½ÅÄ¡·áµ¿Çâ, ¼öºÎ¿Ü°úÀü¹®ÀDZ⺻Áö½Ä : 2018-11-04 0 511 2018-10-11
1394 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦6ȸ ´ëÇѼҾÆÀ̺ñÀÎÈÄ°úÇÐȸ ±³À°°­Á : 2018-11-04 0 624 2018-10-11
1393 ÀüºÏ ÀüºÏ´ëº´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ Æó¾Ï°ËÁø Àü±¹±³À° (Àü¶ó) : 2018-11-03 0 858 2018-10-11
1392 ¼­¿ï ´ëÇÑ°¡Á¤ÀÇÇÐȸ Á¦4ȸ °¡Á¤ÀÇ, È£½ºÇǽº ¿ÏÈ­ÀÇ·á Àü¹®°¡ µÇ±â : 2018-11-03 0 375 2018-10-11
1391 ´ë±¸ ´ëÇѽÉÀåÇÐȸ ´ëµ¿¸Æ ¸»ÃÊÇ÷°ü Áúȯ ½ÉÆ÷Áö¿ò : 2018-11-03 0 431 2018-10-11
1390 ¼­¿ï ´ëÇѾȰúÇÐȸ Á¦120ȸ Çмú´ëȸ (2ÀÏÂ÷) : 2018-11-03 0 1,935 2018-10-11
1389 °æ³² Å뿵½ÃÀÇ»çȸ ¿¬¼ö±³À°(ÀÎÁö±â´ÉÀúÇÏ°ü¸®, ½ÉÀåÁúȯ, ôÃß ³»½Ã°æ¼ö¼ú) : 2018-11-03 0 724 2018-10-11
1388 ¼­¿ï ºÎ»ê´ëº´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ Æó¾Ï°ËÁø Àü±¹±³À° (ºÎ»ê¡¤°æ³²) : 2018-11-03 0 3,141 2018-10-11
1387 ´ëÀü Ãæ³²´ëÇб³º´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ Æó¾Ï°ËÁø Àü±¹±³À° (´ëÀü¡¤Ãæû) : 2018-11-03 0 469 2018-10-11
1386 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ Æó¾Ï°ËÁø Àü±¹±³À° (°­¿ø) : 2018-11-03 0 492 2018-10-11
1385 ¼­¿ï ´ëÇѳ²¼º°úÇÐȸ 2018 International Joint Meeting of Men¡¯s Health and Aging : 2018-11-03 0 584 2018-10-11
1384 Àü³² 2018 Àü¶ó³²µµÀÇ»çȸ ±Ç¿ªº° Ãß°èÇмú´ëȸ(¸ñÆ÷Áö±¸) : 2018-11-03 0 644 2018-10-11
1383 Àü³² 2018 Àü¶ó³²µµÀÇ»çȸ ±Ç¿ªº° Ãß°èÇмú´ëȸ(³ªÁÖÁö±¸) : 2018-11-03 0 821 2018-10-11
1321 | 1322 | 1323 | 1324 | 1325 | 1326 | 1327 | 1328 | 1329 | 1330
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷